Fasolo Peter
SEC CIK 1509999 · EDGAR
BoughtSold
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Fasolo Peter made no open-market trades at JNJ in the last 12 months.
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +925 | 112.5K | +0.8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $157.85 | -474 | 112.1K | -0.4% | -$74.8K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +15.0K | 118.6K | +14% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $157.40 | -7,019 | 111.6K | -6% | -$1.10M |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,135 | 104.5K | +2% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $156.33 | -781 | 103.7K | -0.7% | -$122.1K |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | D - Sale to Iss | $0.00 | -232 | 102.5K | -0.2% | $0 | |
| D | 2023-08-25 | 2023-08-23 | KVUE | Kenvue | Fasolo Peter | Dir | J - Other | — | +1,863 | 1,863 | New | — |
| 2023-07-27 17:52 | 2023-07-25 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $170.32 | -20.0K | 102.7K | -16% | -$3.41M | |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | A - Grant | $0.00 | +12.5K | 128.5K | +11% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $162.01 | -5,765 | 122.7K | -4% | -$934.0K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,078 | 116.8K | +2% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $162.08 | -761 | 116.0K | -0.7% | -$123.3K |
| M | 2022-10-26 19:21 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.36 | -29.3K | 114.7K | -20% | -$5.02M |
| M | 2022-10-26 19:21 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.19 | -20.9K | 144.0K | -13% | -$3.57M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.22 | -13.0K | 164.8K | -7% | -$2.23M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.14 | -8,256 | 179.9K | -4% | -$1.41M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.13 | -4,263 | 184.9K | -2% | -$729.5K |
| D | 2022-10-26 19:20 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $115.67 | +78.5K | 193.1K | +68% | +$9.08M |
| DM | 2022-10-26 19:20 | 2022-10-24 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale+OE | $171.02 | -2,815 | 189.8K | -1% | -$481.4K |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -22.9K | 114.7K | -17% | -$3.76M |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -29.9K | 136.2K | -18% | -$4.93M |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -13.7K | 167.5K | -8% | -$2.25M |
| D | 2022-10-21 16:31 | 2022-10-19 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $101.87 | +70.1K | 184.8K | +61% | +$7.14M |
| DM | 2022-10-21 16:31 | 2022-10-19 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | S - Sale+OE | $164.50 | -3,613 | 181.2K | -2% | -$594.3K |
| D | 2022-02-17 06:00 | 2022-02-14 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +11.2K | 118.5K | +10% | $0 |
| D | 2022-02-17 06:00 | 2022-02-14 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $165.89 | -5,114 | 114.7K | -4% | -$848.4K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,036 | 109.4K | +2% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Fasolo Peter | EVP, Chief HR Off | F - Tax | $168.85 | -743 | 108.6K | -0.7% | -$125.5K |
Purchase Sale Sale after option exercise All abbreviations